跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 778 条关于
“SNAC”
全部
778
临床试验
632
药物
84
机构
4
资讯
58
去年
Lexaria Bioscience Initiates Phase 1b Study Evaluating DehydraTECH-Enhanced GLP-1 Drugs
6个月前
Samchundang Secures $4 Billion European GLP-1 Deal with Breakthrough Patent-Circumventing Technology
去年
Lexaria's DehydraTECH GLP-1 Study Receives Ethics Board Approval, Aims to Enhance Oral Delivery of Diabetes and Weight Loss Drugs
去年
Novo Nordisk Seeks EMA Approval for First Oral GLP-1 Diabetes Treatment
去年
Gan & Lee's Oral GLP-1 Agonist GZR18 Shows Promise in Phase 1 Trial
8个月前
Lexaria's DehydraTECH-Semaglutide Shows 48% Reduction in Side Effects Compared to Rybelsus in Phase 1b Trial
5个月前
Samchundang Pharmaceutical Completes Global Patent Restructuring for S-PASS Oral Drug Delivery Platform
17天前
CHFA Names Eight Emerging Canadian Wellness Brands as Finalists for 2026 Launch Pad Competition
2个月前
Novo Nordisk Enters Agreement with Vivani Medical to Evaluate Ultra-Long-Acting Semaglutide Implant for Chronic Weight Management
去年
Tharimmune Reports Breakthrough in Oral Delivery of TNF-α Inhibitor for Inflammatory Diseases
第 1 页,共 6 页
上一页
下一页